MOE Key Laboratory of Rare Pediatric Diseases & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410000, China; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
MOE Key Laboratory of Rare Pediatric Diseases & Hunan Key Laboratory of Medical Genetics, School of Life Sciences, and Department of Psychiatry, The Second Xiangya Hospital, Central South University, Changsha, Hunan 410000, China; Institute of Rare Diseases, West China Hospital, Sichuan University, Chengdu, China.
Am J Hum Genet. 2024 Nov 7;111(11):2444-2457. doi: 10.1016/j.ajhg.2024.09.001. Epub 2024 Oct 2.
Research on brain expression quantitative trait loci (eQTLs) has illuminated the genetic underpinnings of schizophrenia (SCZ). Yet most of these studies have been centered on European populations, leading to a constrained understanding of population diversities and disease risks. To address this gap, we examined genotype and RNA-seq data from African Americans (AA, n = 158), Europeans (EUR, n = 408), and East Asians (EAS, n = 217). When comparing eQTLs between EUR and non-EUR populations, we observed concordant patterns of genetic regulatory effect, particularly in terms of the effect sizes of the eQTLs. However, 343,737 cis-eQTLs linked to 1,276 genes and 198,769 SNPs were found to be specific to non-EUR populations. Over 90% of observed population differences in eQTLs could be traced back to differences in allele frequency. Furthermore, 35% of these eQTLs were notably rare in the EUR population. Integrating brain eQTLs with SCZ signals from diverse populations, we observed a higher disease heritability enrichment of brain eQTLs in matched populations compared to mismatched ones. Prioritization analysis identified five risk genes (SFXN2, VPS37B, DENR, FTCDNL1, and NT5DC2) and three potential regulatory variants in known risk genes (CNNM2, MTRFR, and MPHOSPH9) that were missed in the EUR dataset. Our findings underscore that increasing genetic ancestral diversity is more efficient for power improvement than merely increasing the sample size within single-ancestry eQTLs datasets. Such a strategy will not only improve our understanding of the biological underpinnings of population structures but also pave the way for the identification of risk genes in SCZ.
脑表达数量性状基因座(eQTL)的研究阐明了精神分裂症(SCZ)的遗传基础。然而,这些研究大多集中在欧洲人群,导致对人群多样性和疾病风险的理解有限。为了解决这一差距,我们检查了非裔美国人(AA,n=158)、欧洲人(EUR,n=408)和东亚人(EAS,n=217)的基因型和 RNA-seq 数据。当比较 EUR 和非 EUR 人群之间的 eQTL 时,我们观察到遗传调控效应的一致模式,特别是在 eQTL 效应大小方面。然而,我们发现 343737 个 cis-eQTL 与 1276 个基因和 198769 个 SNP 相关,这些基因和 SNP 仅存在于非 EUR 人群中。超过 90%的观察到的 eQTL 人群差异可以追溯到等位基因频率的差异。此外,这些 eQTL 中有 35%在 EUR 人群中明显罕见。将脑 eQTL 与来自不同人群的 SCZ 信号整合,我们观察到在匹配人群中脑 eQTL 与疾病的遗传相关性比不匹配人群更高。优先分析确定了五个风险基因(SFXN2、VPS37B、DENR、FTCDNL1 和 NT5DC2)和三个在已知风险基因(CNNM2、MTRFR 和 MPHOSPH9)中潜在的调节变体,这些变体在 EUR 数据集中被遗漏。我们的研究结果表明,增加遗传祖先多样性比仅在单一祖先 eQTL 数据集中增加样本量更有效地提高功效。这种策略不仅将提高我们对人口结构生物学基础的理解,还为 SCZ 中风险基因的鉴定铺平道路。